chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 5-7 minutes after receiving the vaccination, the patient passed out for a couple of seconds while still seated. Her mother was right next to her in the pharmacy waiting area and was able to support her as this happened, and keep her in the chair. Her lips stayed pale/blue for several more minutes and the patient also vomited a very small amount a couple of times. Orange juice and crackers were retrieved from the store to help her get back to feeling normal. Her mother says she had never had a reaction like this before, but her sister had just received the same vaccine and had almost the exact same reaction right before her.
13 days after receiving an MMR booster my son starting running a high temp, peaking at 104. He was under doctors care. It lasted a week.
rash x 3 days, T105, dehydration;mom took pt to hosp ER-was adm to hosp & given IV fluids;
Body aches, especially to should and hip sockets, lower back, ankles and wrists.
numbness, tingling, weakness, muscle spasms, when falls asleep difficulty getting up, chronic fatigue
12 cm hive-like lesion, warm but not tender to the touch (on left arm). Possible erythema multiforme
On Friday February 12th 2021, I started having a really bad headache. Then, it progressed and I am trying to remember exactly what happened. It went on to feel like a sinus headache. I was sick for the next four days basically with sinus symptoms and extreme sinusitis. I had extreme fatigue and couldn't get up and about basically I was just in bed for that time. On February 15th, 16th and 17th  2021 I contacted my DR but I do not recall what the conversation was. I think on the 16th it was a telehealth appointment because that was 13 minutes long.
mom reports high pitched crying 4-5hr, inconsolable, wouldn't take breast or pacifer;
STARTED AROUND 630PM WITH NOT FEELING WELL; BY 900PM ACHES IN SHOULDERS AND BACK; ALL NIGHT LONG ACHES BECAME WORSE UNTIL AROUND 800AM; AROUND 300AM TEMP 100.6; STAYED LISTLESS UNTIL AROUND 400PM; WHILE FEELING "BETTER" AROUND 600PM. STILL TIRE EASILY.
7/14/08- Mom called stated baby developed temp 104- swollen glands in neck. 7/12/08 after MMR/Varicella given 7/2/08- denies diff breathing or rash. Seen in ER on 7/12/08 and by physician 7/14/08- Dx Viral- Dr wanted to put on antiviral med. but mom refused. COC called 7/14/08 11:00 AM referred reaction as moderate and less likely to have reaction when has #2 MMR. Dr notifed 7/14/08 of visit Imm. with calling COD. Instr mom continue Tyl. with f/u with Dr.
I'm scared to get the second one because of what I've read; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 65 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEAR (non-serious), outcome "unknown", described as "I'm scared to get the second one because of what I've read".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt came in for an OV, complaining of a lump with redness at injection site, pt was Rx'ed ABX.
Information has been received from a certified medical assistant concerning a 4 year old female who on 05-APR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # 669187/1543Z, expiration date 06-FEB-2012) instead of VARIVAX (Merck) (lot # not reported) mistakenly. No adverse event was seen. It was unspecified if the patient sought medical attention. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
The Pfizer COVID-19 Vaccine vials were reconstituted with 1.6mL vs. 1.8mL of normal saline.  This resulted in the patient receiving 33mcg of active vaccine component in the 0.3mL dose instead of the  labeled 30mcg.  This has been disclosed to the patient.  Patient reports feeling fine, no adverse side effects.  Reporting through VAERS is required  given the increase in dose administered.
Patient stated her arm was sore day of and day after shot but with out redness or rash. On Saturday pt said her arm was hot,red, itchy, painful, and raised. The reaction was not at the injection site but lower and spread down the arm away from the injection site.  The patient stated  she was feeling  fine otherwise. The patient also mentioned she was in the sun on Saturday and at a petting zoo/safari park.  I recommended the patient visit her Dr or go to a walk in clinic/hospital if she was really bothered by her arm or not feeling well. She will keep me  updated on how she is feeling and how her arm is doing and if she sees her Dr
Swelling of eyes and face. Light rash on face, neck, chest,  and arms
37 y.o. male presents for evaluation of headache, dizziness. Pt is employee here and had his COVID 19 vaccination, 1st dose, earlier today. States that he had felt fine for about 20-30 minutes s/p injection. Began to develop mild headache, gradually worse, now about 4/10. Not thunderclap. No associated focal weakness/numbness. No visual change/loss. No n/v. No hx of same. + associated vertigo worse w/ movement, resolved when at rest, mostly when he looks to right. No other complaints at this time. Required urgent care visit along with meclizine 25mg given orally symptoms resolved.
Face swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face swelling) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING FACE (Face swelling). At the time of the report, SWELLING FACE (Face swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, on 17-Feb-2021, the patient used a facial cream and had a slight reaction on her face. No relevant concomitant medications were reported. No treatment information was provided.
Wednesday, July 21 at 3 AM I woke up with a high heart rate. I?ve had controlled a fib for six years so I assumed I would convert on my own later in the day. 48 hours later when I had not converted, the on-call nurse, suggested that I go to the ER. I spent four hours in the ER and they told me I was in A fib and also  had A flutter (which was new ) but to consult with my cardiologist. I had an appointment with Dr., my cardiologist on Monday, July 26. He scheduled me for an appointment with an electrophysiologist which I have next Thursday, July 29. 9 days later and I am still in A fib and have an extremely elevated heart rate.  Both the ER physician and my cardiologist say this is not related to the vaccine. Come on, really?!
101.9/100.6 F fever; chills; loss of appetite; hips/ankle/neck severe joint pain.; Headaches; Ear ache; Jaw ache; Muscle pain; Left shoulder pain; Dry nose; Weakness at shot administration site; This is a spontaneous report from a contactable consumer. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 16:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included paracetamol (TYLENOL), birth control pill and calcium carbonate, magnesium carbonate 1500mg (TUMS) all taken for unknown indications from an unknown date. The patient previously took hydro-morphone and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 13Mar2021 at 17:30. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 03:30, the patient experienced fever of 101.9deg/100.6deg F, chills, loss of appetite, hips/ankle/neck severe joint pain, headaches, earache and jaw aches, muscle pain and weakness at shot administration site along with left shoulder pain and dry nose. On 10Apr2021 patient underwent lab tests which include body temperature and the result was 101.9 /100.6 degrees F. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, chills, loss of appetite, hips/ankle/neck severe joint pain, headaches, earache and jaw aches, muscle pain and weakness at shot administration site along with left shoulder pain and dry nose was not recovered.  No follow-up attempts are needed. No further information is expected.
Patient states he was immunized with Moderna vaccine, second shot in April, but he  temporarily misplaced his COVID vaccination card and we do not have the lot numbers of his immunization on file. he developed symptoms of cough, fatigue, body aches, and sore throat on 07/28.  He tested positive for COVID on 7/31/2021.
Patient had received 2 doses of Pfizer vaccines prior to contracting COVID; Patient had received 2 doses of Pfizer vaccines prior to contracting COVID; acute respiratory failure secondary to COVID pneumonia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hospitalization", start date: 2019, stop date: 2019; "Chronic obstructive pulmonary disease" (ongoing); "Congestive heart failure" (ongoing); "Thyroid disorder" (unspecified if ongoing); "wheezing" (unspecified if ongoing); "shortness of breath" (unspecified if ongoing).  Concomitant medication(s) included: ELIQUIS taken for cardiac failure congestive, start date: 2019, stop date: 2021; FUROSEMIDE; LIPITOR; ACETYLSALICYLIC ACID; CITALOPRAM; LOPRESSOR; LEVOTHYROXINE taken for thyroid disorder; SALBUTAMOL taken for wheezing, dyspnoea; SYMBICORT taken for wheezing, dyspnoea. The following information was reported: DRUG INEFFECTIVE (death, hospitalization, medically significant), COVID-19 PNEUMONIA (death, hospitalization, medically significant), outcome "fatal" and all described as "Patient had received 2 doses of Pfizer vaccines prior to contracting COVID"; ACUTE RESPIRATORY FAILURE (death, hospitalization, medically significant), outcome "fatal", described as "acute respiratory failure secondary to COVID pneumonia ". The patient was hospitalized for drug ineffective, covid-19 pneumonia, acute respiratory failure (start date: 14Sep2021).  The patient date of death was 09Oct2021. The reported cause of death was drug ineffective, covid-19 pneumonia, acute respiratory failure. It was not reported if an autopsy was performed.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Reported Cause(s) of Death: Patient had received 2 doses of Pfizer vaccines prior to contracting COVID; Patient had received 2 doses of Pfizer vaccines prior to contracting COVID; acute  respiratory failure secondary to COVID pneumonia
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 06-JUN-2017, the patient was vaccinated with improperly stored VARIVAX injection, lot # M046004, expiry date: 18-NOV-2018 (dosing details not reported) which was reconstituted with properly stored sterile diluent (MERCK) (lot#, expiry date unknown) for prophylaxis. It was reported that the vaccine was exposed to a temperature range of 6 F to 14 F for a duration of 180 minutes. There was no previous temperature excursion. Data logger was involved. No adverse effects were reported. There were no product quality complaints. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA007776.
MUSCLE TENSION; HEADACHE; This spontaneous report received from a patient concerned a 68 year old male. The patient's height, and weight were not reported. The patient's past medical history included headache.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982 expiry: 23-JUN-2021) dose was not reported, administered on 05-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the subject experienced muscle tension. On 05-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and the outcome of muscle tension was not reported. This report was non-serious.
"Moderna COVID-19 Vaccine EUA"   Nausea, tiredness, sleepiness, loss of appetite, sensitive teeth (left upper and lower side), soreness from injection site.
09/07/2005 phone call from patient. States both arms are swollen, very sore, and arms and hands are numb from elbow to fingers. States could not attend school today because can not carry book bag. Appt. made with pt PCP for this afternoon.
10 JUN 2021:  Reported from County that we provided Janssen after client had 2 doses Pfizer.  Screening sheet shows client did not respond accurately when asked if she had any previous COVID-19 vaccine, her response was ?no?.  Notified that the client had recently finished 2 dose Pfizer COVID-19 vaccination series prior to presenting to our vaccination site for a Janssen COVID-19 vaccination.   4/14/21: Rite-aid, LD LOT EW0161 5/5/21 Rite-aid, LD LOT EW0173 On 26 MAY 2021 client was provided a Janssen COIVD-19 vaccination after responding to the pre-vaccination screening questions in a way to appear eligible for the Janssen vaccination.  No adverse reactions noted at vaccination site or reported by the client to this program after being vaccinated with the Janssen COVID-19 vaccine.
The evening of the date of vaccination, mom reports he said he did not feel like himself, he felt "funny" like a drunken person. Over the next 6 days he developed headache, subjective (tactile) fever, decreased appetite, stomach ache, decreased concentration, difficulty sleeping, and more defiant behavior.  By a wk later, he reverted back to his baseline appetite and behavior. Other than observation and encouragement of rest by his mother, no specific treatment was provided.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021 at 11:58 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Apr-2021 at 11:58 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 21.74.  Concomitant medication of the patient was not reported.  Batch number 007C21A underwent temperature excursion on 27-Apr-2021 with temperature of 35 degrees Fahrenheit at 09:00 AM. These vials were moved to fridge on 19-Apr-2021 and beyond use date for the vials was reported as 19-May-2021. The vaccines moved to clinic on 27-Apr-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and fisher brand traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).
Information has been received from an office receptionist concerning her 19 year old daughter who on an unspecified date was vaccinated with a first dose of Gardasil. The patient's arm was "shaky" after the first injection. On an unspecified date the patient received her 2nd dose of Gardasil. Subsequently, her arm was "jumpy" and she experienced vomiting and diarrhea. Unspecified medical attention was sought. The patient recovered. Additional information has requested. 07/06/07 This is in follow-up to report(s) previously submitted on 4/6/2007. Follow up information has been received froma health professional concerning a 19 year old female who on 13-OCT-2006, AM was vaccinated IM in right arm with a first dose of GARDASIL lot #653978/0955F and on 02-JAN-2007, AM she received IM in to right arm the second dose of GARDASIL lot #653978/0955F. After first vaccination in October 2006, the patient experienced itchy and swollen at injection site. In approximately January 2007, at 6:00 PM patient was dizzy, very tired, had nausea and her arm was shaking and had arm weakness. Her hand would jump by itself once in a while. She was fine the next day. The patient recovered. No additional information is expected.
He came to office for yearly check-up. Gave him GARDASIL and MENACTRA. Like 20 min once he left office mom came running into to office that her son had got in a accident. He went into syncope and collapse because he didn't remember anything that happen. Doctor examine him was ok and able to go home. Lab work was ordered, but has not been done yet.
He reported sharp pain on both sides of his ribs that radiate around the sides towards his back that is present with deep inspiration and coughing Symptoms started shortly after receiving his 2nd Covid vaccine  - MD Notes  The onset of his first episode of chest pain was 5 days after his first pfizer covid vaccine. His second episode of chest pain started 3 days after his second Pfizer covid vaccine  Adm - 4/13-4/16 & 5/1-5/3/21
This spontaneous report was received from a nurse and a physician via company representative referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. About 3 weeks ago (approximately in May 2016), the patient was vaccinated with M-M-R II injection (lot # L043704 (reporter has requested a lot check), therapy type recombinant human albumin (rHA), Expiry date: 04-NOV-2017 and dose was not reported) subcutaneously. Within 3 minutes after receiving the vaccine dose (onset approximately in May 2016), the patient experienced "a welt about the size of a nickel and redness about the size of a 50 cent piece" at the injection site. The patient did not receive any treatment for the events. The outcome of the events were reported as unknown. The reporter did not provide the causality assessment for the adverse events. There was no Product Quality Complaint (PQC) involved. This is one of the several reports from the same reporter. Additional information has been requested.
The pt had a medium to large hard raised bump that continued for the first month. Two months later there is still some hardness in the same are the DTP was given.
Pain in calves of both legs (Patient rated pain as a 10 with 1 being the lease pain and 10 the worst pain) weakness in legs
Patient with MS stated that when she took her TDAP vaccine, she experienced a flare up with her feet and has had trouble walking ever since. Pt also reports bad eyesight; reported by patient did not consent to follow up.
Administered expired vaccine to patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patients, after the manufacture date of expiration.) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Date the vial was initially stored in the refrigerator was unknown. The vial didn't undergo any temperature excursions. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Non-Significant information received.
Had tongue swelling at 2 am on 03/04/2020 the morning after getting the Pfizer COVID vaccine. 1 st dose. Patient did not have any trouble breathing or swolling. He too some benadrly. Home Health Nurse saw the patient at 7:30 am  on 03/04/2021. Patient still had some swelling of the tongue but not having any trouble breathing or any other problems.  Patient is going to take some benadrly though the day. Home health will follow up with him. He was advised to call 911, if he had toruble breathing
A few days after the vaccine, patient got a raised red area on the arm they received the vaccine in.  The area itched and after a few days it went away.
Pt received moderna for their first vaccine and received pfizer for their second. This was due to miscommunication from the admin and the vaccinator. Both were educated.
"I had pain in the right upper arm/shoulder specially with rapid movement. This started shortly after the booster shot and lasted for several months. During that time I went to physical therapy, acupuncture, and chiropractor for help. My PT was at the clinic and said he had seen several similar cases. similar to a frozen shoulder."